Ginkgo biloba: specificity of neuropsychological improvement—a selective review in search of differential effects
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Extracts of Ginkgo biloba are widely used for the treatment of cognitive impairment. Whereas reviews have focused on the question whether ginkgo is effective to enhance cognition in general, little is known about specificity of improvement. This might be crucial for future trials, thus enabling hypotheses about sensitive outcome measures. Therefore, this article summarizes such information, i.e. neuropsychological effects of chronic administration of ginkgo in healthy and cognitively impaired subjects of any age. Objective psychometric test results were considered if they reflected distinct cognitive functions from randomized controlled group‐studies (RCT). We reviewed 29 RCTs yielding 209 placebo‐drug comparisons of psychometric scores in four different cognitive domains comprising 14 sub‐functions. Whereas little specific information can be obtained from trials for treatment of dementia, a pattern of pharmacological actions on cognitive processes emerges here from studies for mild cognitive impairment (MCI), depression, multiple sclerosis and healthy young and elderly subjects. There is consistent evidence that chronic administration improves selective attention, some executive processes and long‐term memory for verbal and non‐verbal material. Further trials should be more comprehensive as there are few data available on some cognitive functions and psychometric flaws in the selection of tests and the interpretation of their results favouring predominantly β‐errors. Thus, though this pattern is encouraging it also asks for a cautious interpretation to date. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddeley, A. D., & Hitch, G. (1974) · Psychology of Learning and Motivation · doi:10.1016/s0079-7421(08)60452-1 · Cited by 9,860
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
Gagnier, J. J., Boon, H., Rochon, P., Moher, D., Barnes, J., Bombardier, C., & for the CONSORT Group* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00013 · Cited by 608
Cited by
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Snitz, B. E. (2009) · JAMA · doi:10.1001/jama.2009.1913 · Cited by 336
Choudhary, D., Bhattacharyya, S., & Bose, S. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1284970 · Cited by 215
Silberstein, R. B., Pipingas, A., Song, J., Camfield, D. A., Nathan, P. J., & Stough, C. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/164139 · Cited by 36
“In a review of 29 randomized clinical trials examining the cognitive effects of GBE, Kaschel [22] concluded that as many as 20.7% of WM tests in chronic GBE trials had yielded significant results.”
BackgroundInfluential
Metadata
- Authors
- Kaschel, R.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2009-06-23
- Volume
- 24
- Issue
- 5
- Pages
- 345-370
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W1991168967
- Cited by
- 50
- References
- 3
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ginkgo biloba: specificity of neuropsychological improvement—a selective review in search of differential effects. https://app.cochat.ai/papers/10.1002/hup.1037
- The paper
- Kaschel, R. (2009). Ginkgo biloba: specificity of neuropsychological improvement—a selective review in search of differential effects. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.1037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.